Eye bank specialists argue that the global corneal transplant shortage is as much a problem of tissue utilization, ...
Research and Development Investment increased by 16.1% YoY to RMB 785.1 million for the 9 months ended September 30, 2026, reflecting the advancement of additional Phase III clinical trials, as well ...
A retrospective study of eleven Chinese children with microtubule-related gene variants links TUBA1A, TUBB2A, TUBB4A and ...
Microbiotica, a clinical-stage biopharma company developing a pipeline of precision microbiome medicines, has presented clinical data with encouraging efficacy from its Phase 1b MELODY-1 trial of ...
Lotus Resources restarted Kayelekera uranium processing after a fire and acid disruption. See what the next quarterly report must show.
Innovent Biologics released updated clinical trial metrics at ESMO 2026 for IBI363/TAK-928, a bispecific fusion protein ...
The colorectal cancer market is expected to grow steadily, driven by the rising incidence of colorectal cancer worldwide and increasing disease awareness. The adoption of targeted therapies, ...
These data support the advancement of FT819 into the ongoing Phase 2 RECLAIM-LN study (FT819-201; NCT07570862) in patients with refractory, moderate-to-severe SLE with lupus nephritis, which uses the ...
These data support the advancement of FT819 into the ongoing Phase 2 RECLAIM-LN study (FT819-201; NCT07570862) in patients with refractory, moderate-to-severe SLE with lupus nephritis, which uses the ...
All three patients in cohort two completed the 28-day toxicity assessment without a dose-limiting toxicity; findings remain preliminary.
Riju Jhunjhunwala appointed Chairman of Malana Power and AD Hydropower. Appointments approved by respective Boards on October ...
AstraZeneca has reported Phase III CLARITY-Gastric01 results for investigational sonesitatug vedotin in CLDN18.2-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results